The Global Fund to fight AIDS, tuberculosis and malaria, a Geneva-based international financing institution created to channel donor funding toward the world’s three deadliest infectious diseases, has confirmed the resolution of a compliance case involving $1.4 million in flagged health expenditures in Cameroon. The confirmation was provided in an exclusive statement from the institution to The Lead Africa. While the financing institution declares the matter settled, the specific terms of the recovery and the application of administrative sanctions remain undisclosed.
- Global Fund Flagged $1.4 Million In Cameroon Expenditures In June 2024
- Global Fund Confirms Settlement Of Cameroon Case, No Details Disclosed
- Prior Audits Identified Irregularities In Global Fund–Supported Programmes
- Allocations Confirmed, Oversight Review In Progress
- No Public Update On Domestic Accountability Actions In Cameroon
The lack of public details concerning the financial resolution has drawn scrutiny from governance watchdogs. Transparency International Cameroon (TI-C), the national chapter of Transparency International, a global non-governmental organization that monitors and publishes data on corruption worldwide, has formally requested that the Ministry of Public Health clarify the status of the $1.4 million reimbursement. The Cameroonian government has remained silent on the reimbursement, despite inquiries regarding the source of the funds and domestic accountability measures.
Global Fund Flagged $1.4 Million In Cameroon Expenditures In June 2024
The dispute originated from a June 11, 2024 official notification sent by the Global Fund Secretariat to Cameroon’s Ministry of Public Health. The document identified $1,395,648.69 in non-compliant or insufficiently documented expenditures within active grant cycles.
Data compiled by independent monitoring organization Aidspan indicates the flagged funds were concentrated in two sectors. A total of $1,095,055.86 was linked to malaria health products managed by the National Malaria Control Programme, while $300,592.83 involved supply chain and storage management costs handled by CENAME, the state-run essential medicines supply agency, and five regional health promotion funds.
The Global Fund established an August 11, 2024 deadline for the Ministry to either submit valid supporting documentation or reimburse the full amount from domestic state revenues. The institution policies explicitly prohibit the use of grant allocations for such reimbursements.
Global Fund Confirms Settlement Of Cameroon Case, No Details Disclosed
In its statement, Benjamin Szlakmann, Global Fund Communications Officer, confirmed the financial dispute is settled but maintained a policy of non-disclosure regarding the specifics.
We can confirm that this matter has been resolved. While the Global Fund does not publicly comment on ongoing recovery matters, it does play a proactive role when it comes to transparency and accountability in all its work. We have zero tolerance for corruption or misuse of funds.
The institution did not specify if the full amount was recovered in cash or if any legal or disciplinary actions were taken against the implementing partners in Cameroon responsible for the initial compliance failures.
Prior Audits Identified Irregularities In Global Fund–Supported Programmes
The 2024 case follows a series of documented irregularities in Cameroon’s management of international health grants. In October 2021, the Audit Bench of the Supreme Court of Cameroon reported that 238 second-hand freezers purchased via Global Fund COVID-19 resources were significantly overpriced. The audit identified a broader pattern of $30 million in irregular expenditures within the Ministry of Public Health.
In October 2024, the Global Fund’s Office of the Inspector General published report GF-OIG-24-014, revealing that staff at the Cameroon National Planning Association for Family Welfare (CAMNAFAW) misappropriated health products. The audit found $3,020,991 in distributions remained unaccounted for. CAMNAFAW was subsequently removed as a principal recipient of grants.
Eva Etongue Mayer, Vice-President of Transparency International Cameroon, and Grant Cycle 8 Expert on Human Rights, links these structural non-compliance patterns to administrative management practices:
Implementing agencies often justify non-compliance with established rules by citing the late disbursement of funds. Under the guise of making up for lost time and avoiding a withdrawal of funding by the donor, they resort to procedural shortcuts, direct awards, lack of verification of service rendered. This manufactured urgency serves as a driver for rationalization: rule-breaking is presented as an act of saving
the project, when it actually opens the door to opaque and unaccountable management.
Allocations Confirmed, Oversight Review In Progress
The resolution of the $1.4 million dispute occurs as Cameroon enters the Global Fund’s eighth replenishment cycle (Grant Cycle 8). In May 2026, the financial institution confirmed Cameroon’s total Grant Cycle 8 allocation at approximately $236.7 million for 2026–2028.
The funding includes $131.5 million for HIV/AIDS, $91.0 million for malaria, and $14.2 million for tuberculosis. This allocation follows the suspension of U.S. bilateral health funding through PEPFAR (the President’s Emergency Plan for AIDS Relief) and the President’s Malaria Initiative in the country. A formal assessment of Cameroon’s co-financing compliance is currently underway ahead of the June 2026 application deadline.
Commenting on the reliance on international grants, Etongue Mayer stated:
Sovereignty begins with the ability to pay for one’s own lunch. Depending on international grants, such as those from the Global Fund, imposes total accountability. Failing to speak truth to power today is to condemn the health credibility and financial sovereignty of Cameroon tomorrow.
No Public Update On Domestic Accountability Actions In Cameroon
Despite the Global Fund’s confirmation that the dispute is resolved, Cameroonian judicial authorities have issued no public statements regarding prosecutions or confirmed sanctions. High-level meetings held in April and May 2025 between Global Fund officials, the Presidency, the Audit Bench, and the Special Criminal Tribunal concluded without any public communiqué regarding the reimbursement.
Transparency International Cameroon has publicly called for a government transparency note regarding the $1.4 million reimbursement. Etongue Mayer warned of the risks associated with institutional silence:
The current silence on the effective reimbursement of the $1.4 million claimed is a major risk signal. It weakens not only the relationship with one donor but also the country’s credibility with the entire international financial community, risking the placement of our institutions on a blacklist of health governance.
Regarding the operational constraints of local anti-corruption mechanisms, TI-C noted that capacity is frequently neutralized by hierarchical pressures, stating:
When serious irregularities and identified red flags, shell companies and blatant conflicts of interest, lead to no legal action or effective recovery, the institutionalization of vulnerability becomes the norm. The resulting sense of impunity neutralizes any desire for reform and durably weakens the State’s credibility with international partners.
Etongue Mayer concluded on the direct impact of these compliance failures on public health delivery:
Every dollar embezzled or mismanaged translates concretely into a loss of
opportunity for 50,000 citizens awaiting vital care.
Methodology
This investigation is based on formal statements obtained from the Global Fund (Benjamin Szlakmann) and Transparency International Cameroon (Eva Etongue Mayer, Vice-President). Operational data was compiled via the Global Fund Data Explorer platform (accessed May 19, 2026), tracking historical disbursements ($1.21 Billion) and allocation data for Grant Cycle 7 and Grant Cycle 8. Additional contextual verification was drawn from Aidspan / Global Fund Observer (Issue 171), and official press releases from Cameroon’s Ministry of Public Health. The Ministry of Public Health did not respond to multiple detailed requests for comment regarding the terms of the reimbursement and domestic administrative sanctions.
